Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ヒトα−N−アセチルガラクトサミニダーゼポリペプチド
Document Type and Number:
Japanese Patent JP6956417
Kind Code:
B2
Abstract:
The present invention provides new forms of human α-N-acetylgalactosaminidase (NAGAL) polypeptide or a functionally active variant or fragment thereof, nucleic acids encoding the same, and related products and uses, including use in methods of treating Fabry disease, Schindler disease or Kanzaki disease.

Inventors:
Felfeken, Wautel
Haysense, Stephen
Application Number:
JP2018532655A
Publication Date:
November 02, 2021
Filing Date:
December 22, 2016
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Oxyrain UK Limited
International Classes:
C12N9/24; A61K31/7088; A61K35/76; A61K38/47; A61K48/00; A61P3/00; A61P9/00; A61P13/12; A61P43/00; C12N1/19; C12N15/56; C12N15/63; C12N15/81; C12P21/00
Domestic Patent References:
JP2013539974A
JP2013505735A
Foreign References:
WO2007058381A1
Other References:
Database DDBJ/EMBL/GenBank [online], Accession No.XM_012638133.1,,<検索日2020年10月13日>,2015年06月01日,PREDICTED: Propithecus coquereli N-acetylgalactosaminidase, alpha- (NAGA), transcript variant X1, mRNA
Database UniProt/GeneSeq [online],Accession No.G3QXZ9 entry ver 29,,<検索日2020年10月13日>,2015年10月14日
Attorney, Agent or Firm:
Takeshi Oshio